Font
Large
Medium
Small
Night
Prev Index    Favorite Next

Chapter 1443 Competitors of New Drugs

This time, the S-level mutant broke into Lanrun Pharmaceutical Technology Laboratory, which caused great damage to the entire laboratory. It not only affected the progress of medical research and development, but also cast a shadow on many researchers in the entire laboratory. The direct result was that the laboratory was shut down for nearly a week before it slowly returned to normal.

Some of the equipment lost in the laboratory were also restored within this week. In order to repair it, it cost about 30 million US dollars to add the damaged equipment.

Some researchers who were frightened in the entire laboratory, with the help of specially hired psychological experts, finally got out of the shadow of the heart and returned to normal and returned to work.

Lanrun Pharmaceutical Technology Laboratory finally reopened the research and development of the new drug "Detox No. 2" a week later, and laboratory backbones such as Guan Kunpeng were also busy.

Seeing this, Qin Lang finally breathed a sigh of relief and quickly urged the five major alliances to strengthen the security of the entire laboratory. The laboratory lost more than a dozen researchers this time, which is really heartbreaking to say.

"M Laboratory...wait, wait until I finish the work at hand, I won't let you go then!"

Qin Lang also hated the mastermind who caused damage to the laboratory.

However, China is really busy recently. Qin Lang couldn't take it off for a while and could only wait for the revenge to be postponed.

After the laboratory returned to normal, Qin Lang also handed over the capture of S-level mutants to the laboratory and asked the laboratory to conduct relevant research and investigation.

If this S-level mutant can be cracked and the S-level mutant is completely transformed into existing ones, then Qin Lang’s previous losses can be greatly compensated. After all, this level of mutant will be of great help to his own combat power.

When Qin Lang handed over this S-level mutant, he also learned some information. The garbled program virus used by the mutant clone was indeed developed by researchers in his own laboratory. It was originally added to crack the self-destructing program of the mutant clone's brain system, but it was not until Qin Lang fought with the S-level mutant, which helped Qin Lang a lot.

...

Jindali Pharmaceutical Technology Laboratory.

"Hahaha, hahaha, our new drug has finally been developed successfully! After pharmacological and toxicological tests, it can be put into the market. Chairman, as a new product for liver and kidney protection, the new drug products studied this time are ten percent stronger than all drugs on the market."

The laboratory director reported to Duan Ritian, chairman of Jindali Pharmaceutical Group. After receiving the news, Duan Ritian was also very happy: "Okay, okay, okay! As long as the new drug is put into the market, you are all heroes, and I will not treat you badly at that time."

After a pause, Duan Ritian said again: "Last time we wanted to get the agency rights of Fushen No. 1 of Lanrun Pharmaceuticals, but CEO Lanrun didn't have eyes and wanted to compete with us for channel markets without making any money. The brat finally formed an alliance with Huairen Pharmaceuticals, which caused our sales market to be squeezed and shrunk a lot."

"This time, our new drug has been successfully developed. We can finally tell them the signs of being dismissed again, grab the occupied markets, and even suppress the other party's limelight! Humph, if you want to fight with me, Duan, you will definitely not have any good results."

Duan Ritian seemed very happy to get the results of the successful development of new drugs. This is a big trump card. I believe that new drugs will definitely make another wave after investing in the current Chinese pharmaceutical market. In order to seize the market share of the pharmaceutical market, he has also brought his competitors to the army.

(This chapter is not finished, please turn the page)

You should know that to create efficient new drugs, relying on new drugs to attack Lanrun Pharmaceutical Company and the entire Lanrun Group will always have better results than using other means.

After all, this can hit Lanrun Pharmaceutical hard from the source, and it may even make Lanrun Pharmaceutical fail, and the huge medical research costs invested will be wasted.

This is the result he wants.

"What's the name of the new drug?"

The new drug product developed by Jindali Pharmaceutical Laboratory this time was a capsule of granules. Duan Ritian thought about it for a while and said, "Just call it Ganshenqing Capsule!"

After deciding his name, Duan Ritian patiently waited confidently for the laboratory to enter the pharmacological and toxicological test of the new drug. After the pharmacological and toxicological test was completed, he could go directly to the market and not be separated from his competitors.

...

All researchers in Qin Lang Lanrun Life Science and Technology Laboratory are still continuing to conduct related research on "Detox No. 2". Because the S-level mutant incident delayed for more than ten days, the research progress of new drugs has slowed down a lot.

And when the entire Lanrun Pharmaceutical Technology Laboratory's research work reached a critical moment, news came from the pharmaceutical market that Jin Dali's Ganshenqing Capsules were launched, and this new drug product actually overlaps with the "detoxification No. 2" idea currently being studied by Lanrun Laboratory.

Suddenly, this important news attracted the attention of all researchers in the laboratory. After Qin Lang received this news, he also attached great importance to it and held a short meeting with the senior management of the laboratory.

At the short meeting, everyone discussed several issues. One was that the new drug products currently developed overlapped with other companies' ideas and whether they still need to be carried out. The second was, if the research and development continues, how to ensure that the new drug products of "Fushen No. 2" can stand out in the market. The key is how to defeat Jindali Group, which developed the "Liganshenqing" capsules.

We have discussed a lot about these two issues. This time, the laboratory has spent tens of millions of dollars to develop new drugs. If we know that the research of "Ligan Shenqing" capsules with similar ideas has been interrupted on the market, Lanrun Laboratory's previous investment will be wasted.

Therefore, the research on "Fushen No. 2" must continue. If you want to stand out in the market and defeat the "liver and kidney clearance" of Jindali Group, Lanrun Laboratory will have to make real efforts to strive for the new drugs developed here to be better than the other party's therapeutic effect.

Qin Lang was not very fond of Jin Dali Group, a competitor. Jin Dali Group once wanted to acquire the production and sales rights of Lanrun Company's "Fu Shen No. 1". She was very unhappy and secretly attacked Qin Lang, but was directly slapped in the face and counterattacked by Qin Lang.

If possible, Qin Lang wouldn't mind trampling this disliked competitor under his feet again. Now he feels that he has to do something.

Although Qin Lang is not an expert in the field of biopharmaceuticals, he has a dual identity in the cultivation world. He is also a master of alchemy and has many alchemy recipes in his hands. Among them, some excellent alchemy recipes are he feels that he can learn from the development of "Detox No. 2".

After the meeting, Qin Lang directly copied several pill recipes related to body detoxification and compared them to relevant researchers in the laboratory.

The relevant experts in the laboratory who obtained these pill recipes were all surprised. The lords, ministers, and assistants of these pills were so well matched that a wonderful balance was formed between the drugs. It can be said that these pill recipes are definitely priceless.

(This chapter is not finished, please turn the page)

"It's amazing... These pill recipes can be used directly to prescribe medicine. I believe they have miraculous effects in detoxification, nourishing the liver and protecting the kidneys! Of course, if you improve it and further refine it, I believe the effect will be even more magical!"

Therefore, based on Qin Lang's several elixir recipes, Lanrun Pharmaceutical Technology Laboratory then entered a intensive and in-depth research. Now, the researchers in the laboratory who have obtained new ideas are all very energetic. I believe that the new medicine will be successfully developed in no time.

Around the fourth day after Lanrun's competitor Jindali's "Liver and Shenqing" was listed, there was also a cheer from Qin Lang's Lanrun Pharmaceutical Technology Laboratory, and "Detox No. 2" was finally researched!

Although "Detox No. 2" was developed nearly a week later than its competitor "Liver and Shenqing" before it was developed, it is necessary to consider the impact of the S-level mutant striking the laboratory, otherwise "Detox No. 2" would definitely appear earlier than "Liver and Shenqing".

After pharmacological and toxicological tests, the results of "Detox No. 2" are very gratifying. The effect of the same type of drugs on the market is at least more than half in terms of efficacy. Even the new drug "Liver and Shenqing" produced by its competitor Jin Dali cannot compare with it.

I believe that after Lanrun Pharmaceutical's second new drug is launched, it will definitely trigger a sales frenzy in the domestic and foreign markets.

After all, the new drugs developed based on the Dan prescriptions provided by Qin Lang are so effective, so good that it is unimaginable. I believe that as soon as Detox No. 2 is born, the market share of other drugs of the same category will be greatly squeezed.

Even the new drug product of competitor Jindali Pharmaceutical Group, "Liver and Kidney Clear", will be a victim of success. The entire market is so naked, either you die or I die.

As soon as the new drug "Detox No. 2" came out, Lanrun Pharmaceutical Technology began to apply for patents to relevant domestic and international departments. After a batch of patents was released, it could be produced on a large scale, and then it was directly circulated to the market through previous medical channels.

After the new drug "Liver and Shenqing" was launched, Jindali Pharmaceutical Group responded well in the market. It quickly occupied the leading position on the sales list of related drugs for detoxifying, protecting and nourishing liver, and suppressing other drugs of the same category tightly.

If it weren't for the high retail price of "liver and kidney clearance" in the market, it could be called a luxury drug category. Without the price war with other drugs of the same category, I'm afraid other drugs of the same category would have no way to survive.

Currently, the retail price of "Liver and Shenqing" in the market is 351 bottles, and each bottle is about 100 pills. Patients can take it for about a month, and the price is relatively high. Other drugs of the same category are basically only one tenth to one fifth of the "Liver and Shenqing".

When the new drug "Liver and Shenqing" came out of Jin Dali's factory, the cost was only about three yuan per bottle, which was definitely a huge profit.

Black is definitely black! It doesn’t take into account the purchasing power of the majority of patients at all.

Although the price of new drugs is very high, most patients with liver disease and kidney disease on the market would rather choose Jin Dali’s “liver and kidney clearance” in order to achieve efficacy. Unless they really have no money, they would not choose those low-priced drugs with slightly worse efficacy.

This is also impossible. Everyone is sick. In order to get the disease as effective as possible, patients often pay a lot of money at the cost.

As soon as the new drug "Liver and Kidney Clearance" was released, Jindali Group immediately made a fortune. However, when everyone in Jindali, including Chairman Duan Ritian, was smiling and making money, another round of crisis in the pharmaceutical market came quietly.

(End of this chapter)
Chapter completed!
Prev Index    Favorite Next